SCHEDULE 13G/A: Nantahala Capital Management Discloses 9.99% Stake in BiomX Inc.

Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, has reported a beneficial ownership of 9.99% in BiomX Inc.'s common stock as of March 31, 2025.

Summary

• Nantahala Capital Management, LLC, Wilmot B. Harkey, and Daniel Mack (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G.
• As of March 31, 2025, the Reporting Persons beneficially own an aggregate of 2,494,197 shares of BiomX Inc.'s common stock.
• This ownership represents 9.99% of the total outstanding shares of BiomX Inc.'s common stock.
• The reported shares include 888 shares that may be acquired by the Reporting Persons within sixty days through the exercise of warrants.
• Nantahala Capital Management, LLC is a Massachusetts limited liability company and an investment adviser.
• Wilmot B. Harkey and Daniel Mack are citizens of the United States and are filing as control persons in respect of shares beneficially owned by Nantahala.
• The Reporting Persons hold shared voting power and shared dispositive power over all 2,494,197 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of BiomX Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or outlook. It is a neutral regulatory filing.

Future Outlook

NA

Industry Context

This filing indicates a significant passive investment by Nantahala Capital Management in BiomX Inc., a biotechnology company. Such filings are common for institutional investors accumulating stakes in public companies, reflecting their investment strategy rather than operational or strategic changes within the company itself.

Related Party Transactions

• BLACKWELL PARTNERS LLC SERIES A, a fund advised by Nantahala, has the right to receive or direct the receipt of dividends or proceeds from the sale of more than five percent of the outstanding shares of common stock beneficially owned by Nantahala.

Stakeholder Impact

• Shareholders: The disclosure of a significant 9.99% stake by an institutional investor like Nantahala Capital Management may be viewed positively by other shareholders as a vote of confidence in BiomX Inc., potentially influencing market perception and liquidity.

Key Dates

Keywords

BiomX Inc., Nantahala Capital Management, Wilmot B. Harkey, Daniel Mack, Schedule 13G, beneficial ownership, common stock, investment adviser, equity stake